Semaglutide vs Empagliflozin: Which Drug Has Better Real-World Adherence?
Medication adherence comparison between semaglutide and empagliflozin in T2D found differences in persistence and compliance, informing drug selection for treatment sustainability.
Quick Facts
What This Study Found
Medication adherence comparison between semaglutide and empagliflozin in T2D found differences in persistence and compliance, informing drug selection for treatment sustainability.
Key Numbers
Retrospective study comparing adherence and persistence between semaglutide and empagliflozin using pharmacy dispensing data.
How They Did This
Study methodology detailed in the full publication.
Why This Research Matters
These findings have practical implications for the growing number of patients using peptide-based therapies.
The Bigger Picture
This study contributes to the expanding evidence for peptide therapeutics in clinical practice.
What This Study Doesn't Tell Us
Study limitations in the full publication.
Questions This Raises
- ?What are the long-term implications?
- ?How do results compare to other evidence?
- ?What further research is needed?
Trust & Context
- Key Stat:
- Key finding Medication adherence comparison between semaglutide and empagliflozin in T2D found differences in pe
- Evidence Grade:
- Evidence level based on study design in publication.
- Study Age:
- Published in 2025.
- Original Title:
- Medication Adherence to Semaglutide versus Empagliflozin in Adults with Type 2 Diabetes: A Retrospective Observational Study in Saudi Arabia.
- Published In:
- Patient preference and adherence, 19, 4179-4190 (2025)
- Authors:
- Ali, Mostafa A S, Amirthalingam, Palanisamy(3), Alshareef, Hanan(2), Alqifari, Saleh F, Elsaid Hamdan, Ahmed Mohsen, Alatawi, Olayan, Hakami, Faris Ahmed M, Albalawi, Nader Salem, Aljabri, Ahmed
- Database ID:
- RPEP-09865
Evidence Hierarchy
Frequently Asked Questions
What does this mean for patients?
Medication adherence comparison between semaglutide and empagliflozin in T2D found differences in persistence and compliance, informing drug selection for treatment sustainability.
How reliable is this?
Consult the full publication and healthcare provider.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09865APA
Ali, Mostafa A S; Amirthalingam, Palanisamy; Alshareef, Hanan; Alqifari, Saleh F; Elsaid Hamdan, Ahmed Mohsen; Alatawi, Olayan; Hakami, Faris Ahmed M; Albalawi, Nader Salem; Aljabri, Ahmed. (2025). Medication Adherence to Semaglutide versus Empagliflozin in Adults with Type 2 Diabetes: A Retrospective Observational Study in Saudi Arabia.. Patient preference and adherence, 19, 4179-4190. https://doi.org/10.2147/PPA.S569096
MLA
Ali, Mostafa A S, et al. "Medication Adherence to Semaglutide versus Empagliflozin in Adults with Type 2 Diabetes: A Retrospective Observational Study in Saudi Arabia.." Patient preference and adherence, 2025. https://doi.org/10.2147/PPA.S569096
RethinkPeptides
RethinkPeptides Research Database. "Medication Adherence to Semaglutide versus Empagliflozin in ..." RPEP-09865. Retrieved from https://rethinkpeptides.com/research/ali-2025-medication-adherence-to-semaglutide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.